Use of pharmacy refill data as a measure of antiretroviral adherence
Purchase on Springer.com
$39.95 / €34.95 / £29.95*
Rent the article at a discountRent now
* Final gross prices may vary according to local VAT.
Pharmacy refill adherence has become an increasingly important measure of adherence to antiretroviral medications. It offers a simple, inexpensive, and valid method for measuring adherence. Over the past year, there have been several published developments in the use of pharmacy refill data to measure adherence. Given the utility of this adherence measurement, it is likely that pharmacy refill will be the method of choice for measuring antiretroviral adherence in an increasing number of clinical and research settings.
- Steiner JF, Koepsell TD, Fihn SD, Inui TS: A general method of compliance assessment using centralized pharmacy records. Description and validation. Med Care 1988, 26:814–823. CrossRef
- Steiner JF, Prochazka AV: The assessment of refill compliance using pharmacy records: methods, validity, and applications. J Clin Epidemiol 1997, 50:105–116. CrossRef
- Low-Beer S, Yip B, O’shaughnessy MV, et al.: Adherence to triple therapy and viral load response. J Acquir Immune Defic Syndr 2000, 23:360–361.
- Grossberg R, Zhang Y, Gross R: A time-to-prescription-refill measure of antiretroviral adherence predicted changes in viral load in HIV. J Clin Epidemiol 2004, 57:1107–1110. CrossRef
- Wood E, Montaner JS, Yip B, et al.: Adherence to antiretroviral therapy and CD4 T-cell count responses among HIV-infected injection drug users. Antivir Ther 2004, 9:229–235.
- Wood E, Hogg RS, Yip B, et al.: The impact of adherence on CD4 cell count responses among HIV-infected patients. J Acquir Immune Defic Syndr 2004, 35:261–268. CrossRef
- Harrigan PR, Hogg RS, Dong WW, et al.: Predictors of HIV drug-resistance mutations in a large antiretroviral-naive cohort initiating triple antiretroviral therapy. J Infect Dis 2005, 191:339–347. CrossRef
- Wood E, Hogg RS, Yip B, et al.: Effect of medication adherence on survival of HIV-infected adults who start highly active antiretroviral therapy when the CD4+ cell count is 0.200 to 0.350 × 10(9) cells/L. Ann Intern Med 2003, 139:810–816.
- Wood E, Montaner JS, Yip B, et al.: Adherence and plasma HIV RNA responses to highly active antiretroviral therapy among HIV-1 infected injection drug users. CMAJ 2003, 169:656–661.
- Palepu A, Tyndall MW, Joy R, et al.: Antiretroviral adherence and HIV treatment outcomes among HIV/HCV co-infected injection drug users: the role of methadone maintenance therapy. Drug Alcohol Depend 2006, 84:188–194. CrossRef
- Turner BJ, Laine C, Cosler L, Hauck WW: Relationship of gender, depression, and health care delivery with antiretroviral adherence in HIV-infected drug users. J Gen Intern Med 2003, 18:248–257. CrossRef
- Turner BJ, Newschaffer CJ, Zhang D, et al.: Antiretroviral use and pharmacy-based measurement of adherence in postpartum HIV-infected women. Med Care 2000, 38:911–925. CrossRef
- Laine C, Newschaffer CJ, Zhang D, et al.: Adherence to antiretroviral therapy by pregnant women infected with human immunodeficiency virus: a pharmacy claims-based analysis. Obstet Gynecol 2000, 95:167–173. CrossRef
- Gross R, Zhang Y, Grossberg R: Medication refill logistics and refill adherence in HIV. Pharmacoepidemiol Drug Saf 2005, 14:789–793. CrossRef
- Braitstein P, Justice A, Bangsberg DR, et al.: Hepatitis C coinfection is independently associated with decreased adherence to antiretroviral therapy in a population-based HIV cohort. AIDS 2006, 20:323–331. CrossRef
- Braithwaite RS, Kozal MJ, Chang CC, et al.: Adherence, virological and immunological outcomes for HIV-infected veterans starting combination antiretroviral therapies. AIDS 2007, 21:1579–1589. CrossRef
- Gross R, Yip B, Lo Re V 3rd, et al.: A simple, dynamic measure of antiretroviral therapy adherence predicts failure to maintain HIV-1 suppression. J Infect Dis 2006, 194:1108–1114. CrossRef
- Gardner EM, Burman WJ, Maravi ME, Davidson AJ: Durability of adherence to antiretroviral therapy on initial and subsequent regimens. AIDS Patient Care STDS 2006, 20:628–636. CrossRef
- Nachega JB, Hislop M, Dowdy DW, et al.: Adherence to highly active antiretroviral therapy assessed by pharmacy claims predicts survival in HIV-infected South African adults. J Acquir Immune Defic Syndr 2006, 43:78–84. CrossRef
- Nachega JB, Hislop M, Dowdy DW, et al.: Adherence to nonnucleoside reverse transcriptase inhibitor-based HIV therapy and virologic outcomes. Ann Intern Med 2007, 146:564–573.
- Bisson G, Robertson A, Weinstein R: Medication refill cards predict virologic failure in Botswana [abstract TUPE0156]. Presented at the XVI International AIDS Conference. Toronto, Canada; August 13–18, 2006.
- Graham J, Bennett IM, Holmes WC, Gross R: Medication beliefs as mediators of the health literacy-antiretroviral adherence relationship in HIV-infected individuals. AIDS Behav 2007, 11:385–392. CrossRef
- Acri T, Grossberg R, Gross R: Shorter duration pharmacy refill adherence and relation to viral load. Presented at the 2006 NIMH/IAPAC International Conference on HIV Treatment Adherence. Jersey City, NJ; March 2006.
- Use of pharmacy refill data as a measure of antiretroviral adherence
Current HIV/AIDS Reports
Volume 4, Issue 4 , pp 187-191
- Cover Date
- Print ISSN
- Online ISSN
- Current Science Inc.
- Additional Links